ScholarLens Back to search
1997•PubMedRequires access

[Hormonal replacement therapy and body weight in postmenopausal women].

Rafał Ciepłuch, E Czestochowska

Open publisher page 0 citations

Abstract

Prospective studies that included 116 postmenopausal women on hormonal replacement therapy (transdermal estradiol and medroxyprogesterone acetate orally) was performed. Body mass index (BMI), total cholesterol concentration, levels of HDL and LDL-cholesterol were measured before and after 6 and 12 months of continuous treatment. Body mass index revealed no changes during one year of therapy. HDL-cholesterol significantly increased (p < 0.05) and LDL-cholesterol was significantly decreased after 6 and 12 months of HRT.

About this research paper

What this paper is about

Prospective studies that included 116 postmenopausal women on hormonal replacement therapy (transdermal estradiol and medroxyprogesterone acetate orally) was performed. Body mass index (BMI), total cholesterol concentration, levels of HDL and LDL-cholesterol were measured before and after 6 and 12 months of continuous treatment. Body mass index revealed no changes during one year of therapy. HDL-cholesterol significantly increased (p < 0.05) and LDL-cholesterol was significantly decreased after 6 and 12 months of HRT.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Prospective studies that included 116 postmenopausal women on hormonal replacement therapy (transdermal estradiol and medroxyprogesterone acetate orally) was performed. Body mass index (BMI), total cholesterol concentration, levels of HDL and LDL-cholesterol were measured before and after 6 and 12 months of continuous treatment. Body mass index revealed no changes during one year of therapy. HDL-cholesterol significantly increased (p < 0.05) and LDL-cholesterol was significantly decreased after 6 and 12 months of HRT.

Key concepts: Medroxyprogesterone acetate, Body mass index, Transdermal, Medicine, Hormonal replacement therapy, Hormone replacement therapy (female-to-male), Medroxyprogesterone, Cholesterol

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
[Hormonal replacement therapy and body weight in postmenopausal women]. — Research Paper | ScholarLens